Related references
Note: Only part of the references are listed.Bronchiectasis: an emerging global epidemic
Sanjay H. Chotirmall et al.
BMC PULMONARY MEDICINE (2018)
Macrolide-associated sensorineural hearing loss: A systematic review
Allison K. Ikeda et al.
LARYNGOSCOPE (2018)
Characterization of the Frequent Exacerbator Phenotype in Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis
David Araujo et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Anthony De Soyza et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Timothy Aksamit et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
ECFS best practice guidelines: the 2018 revision
Carlo Castellani et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
The missing ingredient: the patient perspective of health related quality of life in bronchiectasis: a qualitative study
Emily K. Dudgeon et al.
BMC PULMONARY MEDICINE (2018)
Viruses in bronchiectasis: a pilot study to explore the presence of community acquired respiratory viruses in stable patients and during acute exacerbations
Alicia B. Mitchell et al.
BMC PULMONARY MEDICINE (2018)
Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis
Ravishankar Chandrasekaran et al.
BMC PULMONARY MEDICINE (2018)
Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis
Emilie Vallieres et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Tropical Australia is a potential reservoir of non-tuberculous mycobacteria in cystic fibrosis
Laura J. Sherrard et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
European Respiratory Society guidelines for the management of adult bronchiectasis
Eva Polverino et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review
Elyse Cornett et al.
POSTGRADUATE MEDICINE (2017)
Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients
Michael J. Cox et al.
PLOS ONE (2017)
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry
Emily Henkle et al.
CHEST (2017)
A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa A Proof of Concept Study
Pallavi Bedi et al.
CHEST (2017)
Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases
Sandra Hodge et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis
Hamdan Al-Jahdali et al.
ANNALS OF THORACIC MEDICINE (2017)
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Macrolides for Clinically Significant Bronchiectasis in Adults Who Should Receive This Treatment?
Adam T. Hill
CHEST (2016)
Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature Review and Network Meta-analysis
J. Stuart Elborn et al.
CLINICAL THERAPEUTICS (2016)
Recovery of baseline lung function after pulmonary exacerbation in children with primary ciliary dyskinesia
Meera Sunther et al.
PEDIATRIC PULMONOLOGY (2016)
Pediatric bronchiectasis: No longer an orphan disease
Vikas Goyal et al.
PEDIATRIC PULMONOLOGY (2016)
Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis
Robert Wilson et al.
RESPIRATORY MEDICINE (2016)
Diagnostic challenges of bronchiectasis
Guillermo Suarez-Cuartin et al.
RESPIRATORY MEDICINE (2016)
Bronchiectasis: shaking off its orphan status
Paul J. Torzillo
LANCET RESPIRATORY MEDICINE (2016)
The Role of Viral Infection in Pulmonary Exacerbations of Bronchiectasis in Adults A Prospective Study
Yong-hua Gao et al.
CHEST (2015)
Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo
K. M. Hare et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis
Anthony De Soyza et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Challenges in the development of new therapies for bronchiectasis
James D. Chalmers et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand: Thoracic Society of Australia and New Zealand guidelines (vol 202, pg 21, 2015)
A. B. Chang
MEDICAL JOURNAL OF AUSTRALIA (2015)
Increased Peripheral Blood Pro-Inflammatory/Cytotoxic Lymphocytes in Children with Bronchiectasis
G. Hodge et al.
PLOS ONE (2015)
Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis
Ramon Orriols et al.
RESPIRATION (2015)
Inhaled Antibiotics in Cystic Fibrosis (CF) and Non-CF Bronchiectasis
George T. P. Tay et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Toward making inroads in reducing the disparity of lung health in Australian Indigenous and New Zealand Maori children
Anne B. Chang et al.
FRONTIERS IN PEDIATRICS (2015)
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores
Alexandra L. Quittner et al.
THORAX (2015)
The effects of oscillating positive expiratory pressure therapy in adults with stable non-cystic fibrosis bronchiectasis: A systematic review
Annemarie L. Lee et al.
CHRONIC RESPIRATORY DISEASE (2015)
Lung Clearance Index Is a Repeatable and Sensitive Indicator of Radiological Changes in Bronchiectasis
Stephen A. Rowan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection
Charles S. Haworth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The Bronchiectasis Severity Index An International Derivation and Validation Study
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Respiratory Exacerbations in Indigenous Children From Two Countries With Non-Cystic Fibrosis Chronic Suppurative Lung Disease/Bronchiectasis
Gregory J. Redding et al.
CHEST (2014)
A Preliminary Quality of Life Questionnaire-Bronchiectasis A Patient-Reported Outcome Measure for Bronchiectasis
Alexandra L. Quittner et al.
CHEST (2014)
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score
Miguel A. Martinez-Garcia et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
Alessandra Monteiro Brodt et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Antimicrobial treatment of non-cystic fibrosis bronchiectasis
Keith Grimwood et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
M. W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
Indigenous Children From Three Countries With Non-Cystic Fibrosis Chronic Suppurative Lung Disease/Bronchiectasis
Rosalyn J. Singleton et al.
PEDIATRIC PULMONOLOGY (2014)
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials
Alan F. Barker et al.
LANCET RESPIRATORY MEDICINE (2014)
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial
Geraint B. Rogers et al.
LANCET RESPIRATORY MEDICINE (2014)
Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation
Michael M. Tunney et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Epidemiology of Nontuberculous Mycobacterial Infections and Associated Chronic Macrolide Use among Persons with Cystic Fibrosis
Alison M. Binder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
Robert Wilson et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study
Sabina Antoniu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BLESS Randomized Controlled Trial
David J. Serisier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial
Josje Altenburg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Complexity, Temporal Stability, and Clinical Correlates of Airway Bacterial Community Composition in Primary Ciliary Dyskinesia
Geraint B. Rogers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis
Robert Stockley et al.
RESPIRATORY MEDICINE (2013)
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
Claire Andrejak et al.
THORAX (2013)
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
David J. Serisier et al.
THORAX (2013)
Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial
Anne B. Chang et al.
TRIALS (2013)
Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial
Patricia C. Valery et al.
LANCET RESPIRATORY MEDICINE (2013)
The Role of the High-Sensitivity C-Reactive Protein in Patients with Stable Non-Cystic Fibrosis Bronchiectasis
Meng-Heng Hsieh et al.
PULMONARY MEDICINE (2013)
Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
S. L. Kenny et al.
BMJ OPEN RESPIRATORY RESEARCH (2013)
Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non-Cystic Fibrosis Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The Burden of Disease in Pediatric Non-Cystic Fibrosis Bronchiectasis
Nitin Kapur et al.
CHEST (2012)
Bronchiectasis in a Diverse US Population Effects of Ethnicity on Etiology and Sputum Culture
Pamela J. McShane et al.
CHEST (2012)
Clinical Efficacy and Safety of Budesonide-Formoterol in Non-Cystic Fibrosis Bronchiectasis
Miguel Angel Martinez-Garcia et al.
CHEST (2012)
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Gerd Doering et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
Conroy Wong et al.
LANCET (2012)
Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis
Nitin Kapur et al.
PEDIATRIC PULMONOLOGY (2012)
Lower Airway Microbiology and Cellularity in Children With Newly Diagnosed Non-CF Bronchiectasis
Nitin Kapur et al.
PEDIATRIC PULMONOLOGY (2012)
Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis
Laura White et al.
RESPIRATORY MEDICINE (2012)
Ventilation inhomogeneity in children with primary ciliary dyskinesia
Kent Green et al.
THORAX (2012)
A Randomized Controlled Trial of Nebulized Gentamicin in Non-Cystic Fibrosis Bronchiectasis
Maeve P. Murray et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
A. Singanayagam et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
Maurizio Renna et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Do New Zealand Children With Non-Cystic Fibrosis Bronchiectasis Show Disease Progression?
Karen A. Munro et al.
PEDIATRIC PULMONOLOGY (2011)
Pulmonary Exacerbations Are Associated With Subsequent FEV1 Decline in Both Adults and Children With Cystic Fibrosis
Don B. Sanders et al.
PEDIATRIC PULMONOLOGY (2011)
Immunomodulatory Effects of Macrolide Antibiotics - Part 2: Advantages and Disadvantages of Long-Term, Low-Dose Macrolide Therapy
J. Altenburg et al.
RESPIRATION (2011)
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
Don B. Sanders et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Longitudinal Growth and Lung Function in Pediatric Non-Cystic Fibrosis Bronchiectasis What Influences Lung Function Stability?
Nitin Kapur et al.
CHEST (2010)
Respiratory Bacterial Pathogens in the Nasopharynx and Lower Airways of Australian Indigenous Children with Bronchiectasis
Kim M. Hare et al.
JOURNAL OF PEDIATRICS (2010)
Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis
James D. Finklea et al.
RESPIRATORY MEDICINE (2010)
British Thoracic Society guideline for non-CF bronchiectasis
M. C. Pasteur et al.
THORAX (2010)
Diagnóstico y tratamiento de las bronquiectasias
Montserrat Vendrell et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2009)
Chronic Respiratory Symptoms and Diseases Among Indigenous Children
Gregory J. Redding et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2009)
Bronchiectasis Secondary to Primary Immunodeficiency in Children: Longitudinal Changes in Structure and Function
Katerina Haidopoulou et al.
PEDIATRIC PULMONOLOGY (2009)
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
S. Fuschillo et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis
T. Guran et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2008)
Improvement in health status following bronchopulmonary hygiene physical therapy in patients with bronchiectasis
Kugathasan Mutalithas et al.
RESPIRATORY MEDICINE (2008)
Quality of life and inflammation in exacerbations of bronchiectasis
JM Courtney et al.
Chronic Respiratory Disease (2008)
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis
Diana Bilton et al.
CHEST (2006)
Inhaled steroids improve quality of life in patients with steady-state bronchiectasis
Miguel A. Martinez-Garcia et al.
RESPIRATORY MEDICINE (2006)
Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis
J Twiss et al.
THORAX (2006)
Non-tuberculous mycobacteria in patients with bronchiectasis
M Wickremasinghe et al.
THORAX (2005)
Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis
F Kellett et al.
RESPIRATORY MEDICINE (2005)
Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa
ME Drobnic et al.
ANNALS OF PHARMACOTHERAPY (2005)
Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis
AP Watt et al.
THORAX (2004)
Treatment of paediatric non-cystic fibrosis bronchiectasis
EA Edwards et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Paediatric bronchiectasis in the twenty-first century: Experience of a tertiary children's hospital in New Zealand
EA Edwards et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2003)
Bronchial inflammation and colonization in patients with clinically stable bronchiectasis
J Angrill et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa
LA Couch
CHEST (2001)
Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis
AF Barker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
